Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow-to-Debt Ratio
Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of $-649.00K could theoretically repay 0% of its total liabilities ($11.51 Million) in one year. See Sonoma Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sonoma Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2005–2026)
Historical debt coverage capacity for Sonoma Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see SNOA cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Sonoma Pharmaceuticals Inc (2005–2026)
Year-by-year debt coverage analysis for Sonoma Pharmaceuticals Inc. Check earnings quality score of Sonoma Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.36x | $-3.93 Million | $10.87 Million | ▼ -3718.2% |
| 2025 | -0.01x | $-88.00K | $9.28 Million | ▲ +96.6% |
| 2024 | -0.28x | $-2.40 Million | $8.60 Million | ▲ +62.6% |
| 2023 | -0.75x | $-6.15 Million | $8.25 Million | ▼ -78.1% |
| 2022 | -0.42x | $-4.25 Million | $10.15 Million | ▼ -19.3% |
| 2021 | -0.35x | $-3.38 Million | $9.62 Million | ▲ +31.7% |
| 2020 | -0.51x | $-4.59 Million | $8.94 Million | ▲ +82.6% |
| 2019 | -2.96x | $-11.72 Million | $3.96 Million | ▲ +7.7% |
| 2018 | -3.21x | $-12.44 Million | $3.88 Million | ▼ -58.1% |
| 2017 | -2.03x | $-8.17 Million | $4.03 Million | ▲ +15.1% |
| 2016 | -2.39x | $-8.75 Million | $3.66 Million | ▼ -6.8% |
| 2015 | -2.24x | $-6.69 Million | $2.99 Million | ▼ -299.1% |
| 2014 | -0.56x | $-4.89 Million | $8.73 Million | ▼ -513.3% |
| 2013 | 0.14x | $1.15 Million | $8.48 Million | ▲ +129.3% |
| 2012 | -0.46x | $-4.03 Million | $8.71 Million | ▲ +27.2% |
| 2011 | -0.64x | $-4.43 Million | $6.96 Million | ▲ +69.6% |
| 2010 | -2.09x | $-6.64 Million | $3.17 Million | ▲ +60.5% |
| 2009 | -5.30x | $-16.83 Million | $3.18 Million | ▼ -148.5% |
| 2008 | -2.13x | $-17.45 Million | $8.18 Million | ▼ -42.0% |
| 2007 | -1.50x | $-18.08 Million | $12.05 Million | ▲ +60.9% |
| 2006 | -3.83x | $-20.52 Million | $5.35 Million | ▼ -34.3% |
| 2005 | -2.86x | $-13.53 Million | $4.74 Million | — |